Press Release

Clinical Trial Supplies Market to be dominated by Oncology Segment through 2028

Rising research & development of innovative drugs and therapies is expected to drive the growth of Global Clinical Trial Supplies Market during the forecast period.

According to TechSci Research report, “Clinical Trial Supplies Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028,” the rising demand from pharmaceutical companies for evaluating the safety and efficacy of new treatments and therapies has led to the development of biologics and biosimilars requiring clinical trials to establish similarity in terms of safety, efficacy, and quality compared to the reference biologic. These trials necessitate adequate supplies of both the biosimilar and the reference product for comparative evaluations. The rapid progress in biotechnology has opened up new avenues for drug discovery and development. Biotech companies are leveraging technologies such as gene editing, gene therapy, RNA interference, and cell-based therapies to develop innovative treatments. These advanced therapeutic modalities often require extensive clinical testing to assess their safety and efficacy, leading to a higher demand for clinical trials.

Precision medicine, which designs treatments for individual patients based on their genetic makeup and other personalized factors, has gained prominence. Pharmaceutical and biotech companies are investing in R&D efforts to develop targeted therapies for specific patient populations. This personalized approach often necessitates conducting clinical trials with well-defined patient cohorts, resulting in an increased demand for clinical trial participation.

The increase in clinical studies being undertaken on a global scale is expanding the clinical trial supplies market growth. More researchers, pharmaceutical companies, and contract research organizations (CROs) are participating in clinical trials across a wide range of therapeutic areas as a result of improvements in medical understanding and the demand for evidence-based therapy. The need for clinical trial supplies, such as investigational medications, medical devices, laboratory materials, and diagnostic instruments, rises due to the increase in trial activity.

Clinical trials are highly in demand for the development of therapeutic and efficient drug developments. Clinical trials in gastroenterology focus on gastrointestinal disorders such as Crohn's disease, ulcerative colitis, irritable bowel syndrome (IBS), and gastroesophageal reflux disease (GERD). These trials evaluate new medications, biologics, probiotics, dietary interventions, and surgical procedures to enhance disease control, manage symptoms, and improve the quality of life for patients. For instance, clinical trials in endocrinology address disorders of the endocrine system, including diabetes, thyroid diseases, osteoporosis, and hormone-related conditions. Trials may involve testing new insulin formulations, antidiabetic medications, hormonal therapies, and evaluating novel approaches for disease management, prevention, and early detection.

Clinical trials in oncology focus on the development of new cancer treatments, including chemotherapy drugs, targeted therapies, immunotherapies, and radiotherapy techniques. Trials may involve assessing the effectiveness of novel drugs, exploring combination therapies, evaluating the role of immunotherapy in different cancer types, and investigating personalized medicine approaches based on genetic or biomarker profiles.

Moreover, the COVID-19 pandemic has also significantly impacted the demand for clinical trial supplies. The global response to the pandemic has accelerated the development of vaccines, therapeutics, and diagnostics, leading to an unprecedented number of clinical trials related to COVID-19. The urgency to find effective treatments and preventive measures has created an immense demand for trial supplies, including vaccines, monoclonal antibodies, and diagnostic kits.

The globalization of clinical trials has created a need for supplies to be distributed across different geographical locations. This includes sourcing and delivering trial materials to various sites, ensuring consistent quality and adherence to regulatory requirements.

Additionally, technological advancements have revolutionized the field of clinical trials, driving the demand for specialized supplies. For example, the rise of precision medicine and genomics has led to the development of companion diagnostics and targeted therapies. Furthermore, digital health technologies, electronic data capture, and wearables are increasingly incorporated into clinical trials, requiring compatible supplies to support data collection and analysis.

Browse over XX market data Figures spread through
 165 Pages and an in-depth TOC on "Global Clinical Trial Supplies Market

Global Clinical Trial Supplies Market can be segmented based on services, type, therapeutic areas, end user, region, and company.

Based on services, the market is segmented into manufacturing, packaging labeling & binding, logistics & distribution, storage & retention, comparator sourcing, and others. Logistics & distribution are expected to hold the highest share in the forecast period on account of the growing adoption of logistics & distribution in an extended range. Additionally, the rising number of clinical trials and increased globalization of clinical trials are anticipated to propel the growth of this segment.

Based on type, the market can be segmented into small molecule drugs, biologics drugs, and medical devices. The biologics drugs segment is expected to show impressive growth in the forecast period due to growing research & development activities such as the development of biosimilar products and other nanoparticle-based drug delivery systems. Biosimilars and biologics are produced using highly intricate manufacturing techniques using living cells.

Based on therapeutic areas, the market is segmented into oncology, CNS and mental disorders, cardiovascular diseases, digestive disorders, infectious diseases, metabolic disorders, blood disorders, immunology, and other therapeutic disorders. The oncology segment is expected to hold the highest share in the forecast period due to the increasing prevalence of cancer across several regions. Also, the rising research & development along with the growing cancer drug development correspondingly increases the demand for clinical trial supplies.

Based on region, North America dominated the market in 2022 on account of the largest number of clinical trials across the region. Also, technological advancements & government funding are major factors that contributed to the growth of clinical trial supplies market in North America. Asia Pacific is expected to have the highest share in the forecast period. This can be attributed to the existence of a low cost of conducting clinical trials and the easy patient recruitment rate for clinical trials compared to other developed nations.

The leading companies operating in the Global Clinical Trial Supplies Market are:

  • Thermo Fisher Scientific Inc.
  • Catalent Inc
  • Almac Group
  • PRA Health Sciences
  • Piramal Pharma Solutions
  • Clinigen Group Plc
  • Eurofins Scientific SE
  • Parexel International Corporation


Download Free Sample Report

Customers can also request for 10% free customization on this report.

Asia Pacific is expected to dominate the Global Clinical Trial Supplies Market during the forecast period due to the rising prevalence of various chronic diseases and increasing research & development of new therapeutic drugs, leading to increased clinical trials. Additionally, a large patient pool, comparatively lower operating clinical trial costs than other developed countries and increasing governmental support and investments for clinical trials are major factors expected to influence the growth of the global Clinical Trial Supplies Market in the coming years," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“Clinical Trial Supplies Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028

Segmented By Services (Manufacturing, Packaging Labeling & Blinding, Logistics & Distribution, Storage & Retention, Comparator Sourcing, Other), By Type (Small Molecule Drugs, Biologics Drugs, Medical Devices), By Therapeutic Areas ( Oncology, CNS and Mental Disorders Cardiovascular Diseases, Digestive Disorders, Infectious Diseases, Metabolic Disorders, Blood Disorders, Immunology and Other Therapeutic Disorder), By End User (Pharmaceutical, Biotechnology Companies, Contract Research Organizations (CROs)), By Region and Competition,” has evaluated the future growth potential of Global Clinical Trial Supplies Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Clinical Trial Supplies Market.


Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com

Relevant News